Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

The New England Journal of Medicine
H Padma-NathanN Gesundheit

Abstract

Erectile dysfunction in men is common. We evaluated a system by which alprostadil (prostaglandin E1) is delivered transurethrally to treat this disorder. Alprostadil was delivered transurethrally in a double-blind, placebo-controlled study of 1511 men, 27 to 88 years of age, who had chronic erectile dysfunction from various organic causes. The men were first tested in the clinic with up to four doses of the drug (125, 250, 500, and 1000 microg); those who had sufficient responses were randomly assigned to treatment with either the effective dose of alprostadil or placebo for three months at home. During in-clinic testing, 996 men (65.9 percent) had erections sufficient for intercourse. Of these men, 961 reported the results of at least one home treatment; 299 of the 461 treated with alprostadil (64.9 percent) had intercourse successfully at least once, as compared with 93 of the 500 who received placebo (18.6 percent, P<0.001). On average, 7 of 10 alprostadil administrations were followed by intercourse in men responsive to treatment. The efficacy of alprostadil was similar regardless of age or the cause of erectile dysfunction, including vascular disease, diabetes, surgery, and trauma (P<0.001 for all comparisons with placebo)...Continue Reading

References

Oct 1, 1991·The Journal of Urology·W W Kerfoot, C C Carson
Jun 1, 1990·The Journal of Urology·M M LakinL R Schover
Dec 14, 1989·The New England Journal of Medicine·R J KraneI Saenz de Tejada
Sep 1, 1988·The Journal of Urology·M Waldhauser, P Schramek
May 1, 1987·The Journal of Urology·T F Lue, E A Tanagho
Jul 1, 1987·The Journal of Urology·D K Montague
Jan 1, 1994·Neurourology and Urodynamics·F Trigo-RochaE A Tanagho
May 1, 1994·The Journal of Urology·H van AhlenH J Hertfelder
Mar 30, 1993·Hospital Practice·A Morales
May 1, 1993·The Journal of Urology·W MeinhardtJ Zwartendijk
May 1, 1993·The Journal of Urology·M S CooksonW P Fitch
Jul 7, 1993·JAMA : the Journal of the American Medical Association
Dec 1, 1995·Annals of Surgery·C YegenR Yalin

❮ Previous
Next ❯

Citations

Nov 19, 2002·Cancer·Leslie R SchoverPatrick A Kupelian
Jan 5, 2002·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·T F Lue
Nov 4, 2000·Archives of Pharmacal Research·T Y OhW B Kim
Oct 30, 2003·Aging Clinical and Experimental Research·Gaetano Frajese, Flavio Pozzi
Oct 12, 2010·World Journal of Urology·Amira M Senbel
Mar 20, 2003·Current Diabetes Reports·Donald Richardson, Aaron Vinik
Dec 21, 2000·Current Psychiatry Reports·S N Seidman, S P Roose
Dec 21, 2000·Current Psychiatry Reports·R T Segraves
Jun 27, 2002·Current Urology Reports·C C Carson
Jun 27, 2002·Current Urology Reports·A Nehra
Jun 27, 2002·Current Urology Reports·C D ZippeA Agarwal
Nov 12, 2002·Current Urology Reports·Ajay Nehra, Haluk Kulaksizoglu
Nov 12, 2002·Current Urology Reports·Ronald L Yap, Kevin T McVary
Oct 30, 2009·Current Urology Reports·Todd A Linsenmeyer
Nov 5, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·G KarsentyF Bruyère
Feb 13, 1999·Disease-a-month : DM·M E Wierman
May 30, 2001·Urology·E FagelmanR Shabsigh
Dec 31, 1997·Urology·P Werthman, J Rajfer
Jun 3, 1998·Urology·S E Jackson, T F Lue
Jan 14, 1999·Urology·L S MarksP B Santos
Jul 12, 2002·The Urologic Clinics of North America·Mark A Moyad
Jul 6, 2000·Neuroscience and Biobehavioral Reviews·R C Rosen, B D Sachs
Dec 21, 2000·Trends in Pharmacological Sciences·T J BivalacquaP J Kadowitz
May 10, 2002·European Urology·Eric WespesUNKNOWN European Association of Urology
May 20, 1999·Baillière's Clinical Endocrinology and Metabolism·D J Handelsman, P Y Liu
Aug 30, 2008·The Western Journal of Medicine·D A Nachtsheim
Sep 3, 2010·International Journal of Impotence Research·G YangJ Lu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.